|
|
.
See Category: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
See Header: Hemorrhagic disorder due to intrns circ anticoag,antib,inhib
ICD-10 (CM) Code and Descriptor
|
D68.318 |
Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
|
D68318 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 29.59%
|
23.58%
|
13.79%
|
9.69%
|
7.03%
|
4.07%
|
2.87%
|
3.11%
|
1.47%
|
1.71%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D68.318*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85610
|
PROTHROMBIN TIME |
860
|
862
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
663
|
668
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
487
|
493
|
|
85730
|
THROMBOPLASTIN TIME PARTIAL |
401
|
416
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
312
|
314
|
|
80053
|
COMPREHEN METABOLIC PANEL |
303
|
303
|
|
85240
|
CLOT FACTOR VIII AHG 1 STAGE |
243
|
261
|
|
97110
|
THERAPEUTIC EXERCISES |
120
|
149
|
|
97530
|
THERAPEUTIC ACTIVITIES |
119
|
186
|
|
85335
|
FACTOR INHIBITOR TEST |
60
|
66
|
|
97112
|
NEUROMUSCULAR REEDUCATION |
59
|
75
|
|
80048
|
METABOLIC PANEL TOTAL CA |
59
|
60
|
|
99213
|
OFFICE O/P EST LOW 20 MIN |
56
|
56
|
|
J1642
|
INJ HEPARIN SODIUM PER 10 U |
52
|
2,600
|
|
96413
|
CHEMO IV INFUSION 1 HR |
50
|
50
|
|
J7170
|
INJ., EMICIZUMAB-KXWH 0.5 MG |
46
|
14,042
|
|
83540
|
ASSAY OF IRON |
45
|
46
|
|
97116
|
GAIT TRAINING THERAPY |
45
|
48
|
|
J9312
|
INJ., RITUXIMAB, 10 MG |
44
|
1,973
|
|
96415
|
CHEMO IV INFUSION ADDL HR |
43
|
83
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D68.318 related to the following DRG Codes:
813
|
